Oral tolerance elicited in mice by β-lactoglobulin entrapped in biodegradable microspheres

Vaccine

Volumn 18, Issue 13, 2000, Pages 1196-1202

  Pecquet, Sophie ^a   Leo, Eliana ^b   Fritsché, Rodolphe ^a   Pfeifer, Andréa ^a   Couvreur, Patrick ^b   Fattal, Elias ^b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIV PARIS SUD   (France)

Author keywords

Lactoglobulin; Microspheres; Oral tolerance

Indexed keywords

BETA LACTOGLOBULIN; MICROSPHERE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIODEGRADATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; FEMALE; IMMUNOLOGICAL TOLERANCE; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VACCINE PRODUCTION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; INTUBATION, GASTROINTESTINAL; LACTIC ACID; LACTOGLOBULINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; SPLEEN;

EID: 0033988615     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00384-9     Document Type: Article

References (39)

1. Eldridge J.H., Staas J.K., Meulbroek J.A., McGhee J.R., Tice T.R., Gilley R.M. Biodegradable microspheres as vaccine delivery system. Mol. Immunol. 28:1991;287-294.
2. Challacombe S.J., Rahman D., Jeffery H., Davis S.S., O'Hagan D.T. Enhanced secretory IgA and systemic IgG antibody responses after oral immunisation with biodegradable microparticles containing antigen. Immunology. 76:1992;164-168.
3. Shanin R., Leef M., Eldridge J., Hudson M., Gilley R. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(D,L-lactide-co-glycolide) microspheres. Infect. Immun. 63:1995;1195-1200.
4. Tseng J., Komisar J.L., Trout R.N., Hunt R.E., Chen J.Y., Johonson A.J., Pitt L., Ruble D.L. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a super antigen, in monkeys vaccinated with SEB toxoid-containing microspheres. Infect. Immun. 63:1995;2880-2885.
5. Allaoui-Attarki K., Pecquet S., Fattal E., Trolle S., Chachaty E., Couvreur P., Andremont A. Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(D,L-lactide-co-glycolide) microspheres. Infect. Immun. 65:1997;853-857.
6. O'Hagan D.T. Intestinal translocation of particulates. Implications for drug and antigen delivery. Adv. Drug Deliv. Rev. 5:1990;265-285.
7. O'Hagan D.T., Rahman D., McGhee J.R., Jeffery H., Davies M.C., Williams P., Davies S.S., Challacombe S.J. Biodegradable microspheres as controlled relaese antigen delivery systems. Immunology. 73:1991;239-242.
8. Challacombe S.J., Tomasi T.B. Jr. Systemic tolerance and secretory immunity after oral immunisation. J. Exp. Med. 152:1980;1459-1472.
9. Strobel S. Dietary manipulation and induction of tolerance. J. Pediatr. 121:1992;S74-S79.
10. 3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98:1996;70-77.
11. Kleinman R.E., Bahna S., Powell G.F., Sampson H.A. Use of infant formula in infants with cow milk allergy. Pediatr. Allergy Immunol. 4:1991;146-155.
12. Pecquet S., Pfeifer A., Gauldie S., Fritsché R. IgE suppression and cytokine modulation in mice orally tolerised to β-lactoglobulin. Immunology. 96:1999;278-285.
13. Peng H.J., Turner M.W., Strobel S. The kinetics of oral hyposensitisation to a protein antigen are determined by immune status and the timing, dose and frequency of antigen administration. Immunology. 67:1989;425-430.
14. Léo E., Pecquet S., Rojas J., Couvreur P., Fattal E. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly[lactide-co-glycolide] microspheres prepared by a W/O/W solvent evaporation method. J. Microencaps. 15:1998;421-430.
15. Hora M.S., Rana R.K., Nummeberg J.K., Tice T.R., Gilley R.M., Hudson M.E. Release of human serum albumin from poly[lactide-co-glycolide] microparticles. Pharm. Research. 7:1990;1175-1190.
16. Elson C., Ealding W., Lefkowitz J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Methods. 67:1984;101-107.
17. Shirakawa T., Enomoto T., Shimazu S.-I., Hopkin J.M. The inverse association between tuberculin responses and atopic disorder. Science. 275:1997;77-79.
18. Ferguson A., Gillett H., O'Mahony S. Active immunity or tolerance to foods in patients with celiac disease or inflammatory bowel disease. Ann. NY Acad. Sci. 778:1996;202-216.
19. Peng H.-J., Turner M.W., Strobel S. The generation of a "tolerogen" after ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin. Exp. Immunol. 81:1990;510-515.
20. Fritsché R., Pahud J.J., Pecquet S., Pfeifer A. Induction of systemic immunological tolerance to β-lactoglobulin by oral administration of a whey protein hydrolysate. J. Allergy Clin. Immunol. 100:1997;266-273.
21. Troncone R., Ferguson A. Gliadin presented via the gut induces oral tolerance in mice. Clin. Exp. Immunol. 72:1988;284-287.
22. Melamed D., Fishman-Lobell J., Uni Z., Weiner H., Friedman A. Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin. Int. Immunol. 8:1996;717-724.
23. Dahlman-Höglund A., Dahlgren U., Ahlstedt S., Hanson L., Telemo E. Bystander suppression of the immune response to human serum albumin in rats fed ovalbumin. Immunology. 86:1995;128-133.
24. Marth T., Strober W., Seder R., Kelsall B. Regulation of transforming growth factor-β production by interleukin 12. Eur. J. Immunol. 27:1997;1213-1220.
25. Nelson P.A., Akselband Y., Dearborn S.M., Al-Sabbagh A., Tian Z.J., Gonella P.A., Zamvil S.S., Chen Y., Weiner H.L. Effect of oral beta interferon on subsequent immune responsiveness. Ann. NY Acad. Sci. 778:1996;145-155.
26. Holmgren J., Lycke N., Czerkinski C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 11:1993;1179-1184.
27. Sun J.B., Holmgreen J., Czerkinki C. Cholera toxin B subunit: an efficient transmucosal carrier delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA. 91:1994;10795-10799.
28. Tamura S., Shoji Y., Hasigughi K., Aizawa C., Kurata T. Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin. Vaccine. 12:1994;1238-1240.
29. Tamura S., Hatori E., Tsuruhara T., Aizawa C., Kurata T. Suppression of delayed-type hypersensitivity and IgE antibody response to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B sub-unit-conjugated ovalbumin. Vaccine. 15:1997;225-229.
30. O'Hagan D.T., Jeffery H., Roberts M.J.J., McGhee J.P., Davies S.S. Controlled release of microparticles for vaccine development. Vaccine. 9:1991;768-772.
31. Eldrige J.H., Meulbroak J.A., Staas J.K., Tice T.R., Gilley R.M. Vaccine containing biodegradable microspheres specifically enter the gut associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv. Exp. Med. Biol. 251:1989;192-202.
32. Jenkins P.G., Coombes A.G.A., Yeh M.K., Thomas N.W., Davies S.S. Aspects of the design and delivery of microparticles for vaccines applications. J. Drug Target. 3:1995;79-81.
33. Elson C.O., Tomasi M., Dertzbaugh M.T., Thagghard G., Hunter R., Weaver C. Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance. Ann. NY Acad. Sci. 778:1996;156-162.
34. Flanagan M., Jain S., Michael J.G. Breaking of oral tolerance by encapsulated antigen. Ann. NY Acad. Sci. 778:1996;373-375.
35. Friedman A., Weiner H. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA. 91:1994;6688-6694.
36. 2 emulsion solvent evaporation method. Inter. J. Pharm. 111:1994;137-145.
37. Enomoto A., Konishi M., Hachimura S., Kaminogawa S. Milk whey protein fed as a constituent of the diet induced both oral tolerance and a systemic humoral response, while heat denaturated protein induced only oral tolerance. Clin. Immunol. Immunopathol. 66:1993;136-142.
38. Pierre P., Denis O., Bazin H., Mbella Mbongolo E., Vearman J.-P. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit. Eur. J. Immunol. 22:1992;3179-3182.
39. Hearn T.L., Olsen M., Hunter R.L. Multiple emulsions oral vaccine vehicles for inducing immunity or tolerance. Ann. NY Acad. Sci. 778:1996;388-389.